Please assess the completion status of the following clinical trial:

Trial Title: Trial of Aripiprazole in the Treatment of CD in Adolescents

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male post-pubertal adolescents (13-17 years, Tanner Stage 4) diagnosed with conduct disorder.~Exclusion Criteria:~* Clinically significant laboratory and/or ECG abnormalities~* Pre-existing health conditions that would compromise patient safety~* Mental retardation~* Previous use of aripiprazole~* Active psychosis

- Gender: MALE
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Adolescent Conduct Disorder Males (Type: OTHER): All subjects were male and had a diagnosis of conduct disorder. All subjects were offered treatment with aripiprazole.

Based on this trial design, predict the completion outcome and termination type (if applicable).